In breast cancer FOXO3 modulates tumor progression by promoting cell invasion via the induction of matrix metalloproteinases [7] and in pancreatic cancer active FOXO3 correlates with poor prognosis as it acts as an essential regulator of CD44+ stem cells [14, 15]. This evidence concerns the gene FOXO3 and breast cancer.